Kamal Okasha

4.0k total citations · 1 hit paper
27 papers, 2.4k citations indexed

About

Kamal Okasha is a scholar working on Nephrology, Immunology and Infectious Diseases. According to data from OpenAlex, Kamal Okasha has authored 27 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 5 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Kamal Okasha's work include Dialysis and Renal Disease Management (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and COVID-19 Clinical Research Studies (3 papers). Kamal Okasha is often cited by papers focused on Dialysis and Renal Disease Management (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and COVID-19 Clinical Research Studies (3 papers). Kamal Okasha collaborates with scholars based in Egypt, Canada and China. Kamal Okasha's co-authors include Jianzhong Sun, Rania Al-Tohamy, Sameh S. Ali, Yehia A.‐G. Mahmoud, Tamer Elsamahy, Yinyi Fu, Fanghua Li, Haixin Jiao, Nahla E. El‐Ashmawy and Yusuf A. Haggag and has published in prestigious journals such as Journal of Environmental Management, Transplantation and Ecotoxicology and Environmental Safety.

In The Last Decade

Kamal Okasha

25 papers receiving 2.3k citations

Hit Papers

A critical review on the treatment of dye-containing wast... 2022 2026 2023 2024 2022 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamal Okasha Egypt 9 859 777 703 522 310 27 2.4k
Shazia Nouren Pakistan 17 743 0.9× 896 1.2× 440 0.6× 470 0.9× 598 1.9× 32 2.3k
Mário César Guerreiro Brazil 29 862 1.0× 1.0k 1.3× 582 0.8× 726 1.4× 530 1.7× 99 3.1k
Timothy O. Ajiboye South Africa 21 660 0.8× 860 1.1× 722 1.0× 428 0.8× 294 0.9× 57 2.2k
Yongqian Fu China 25 1.1k 1.3× 1.0k 1.3× 695 1.0× 878 1.7× 568 1.8× 85 3.1k
Alenka Majcen Le Maréchal Slovenia 15 725 0.8× 489 0.6× 386 0.5× 375 0.7× 248 0.8× 36 1.8k
Muhammad Imran Din Pakistan 31 690 0.8× 1.6k 2.0× 835 1.2× 726 1.4× 646 2.1× 147 3.4k
Shivani B. Mishra South Africa 30 965 1.1× 971 1.2× 657 0.9× 833 1.6× 665 2.1× 103 3.1k
Ridha Abdelhèdi Tunisia 32 1.4k 1.6× 454 0.6× 855 1.2× 459 0.9× 499 1.6× 63 2.9k
Shraddha Pai India 26 468 0.5× 969 1.2× 389 0.6× 428 0.8× 472 1.5× 54 2.0k
Said Benkhaya Morocco 11 544 0.6× 614 0.8× 245 0.3× 535 1.0× 278 0.9× 15 1.8k

Countries citing papers authored by Kamal Okasha

Since Specialization
Citations

This map shows the geographic impact of Kamal Okasha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamal Okasha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamal Okasha more than expected).

Fields of papers citing papers by Kamal Okasha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamal Okasha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamal Okasha. The network helps show where Kamal Okasha may publish in the future.

Co-authorship network of co-authors of Kamal Okasha

This figure shows the co-authorship network connecting the top 25 collaborators of Kamal Okasha. A scholar is included among the top collaborators of Kamal Okasha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamal Okasha. Kamal Okasha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elshazli, Rami M., et al.. (2024). Genetic Variants of AGO1*rs595961 and AGO2*rs4961280 with Susceptibility to Bladder Carcinoma. Indian Journal of Clinical Biochemistry. 40(4). 576–587. 2 indexed citations
2.
Salem, Mohamed L., et al.. (2023). COVID-19 Severity Shifts the Cytokine Milieu Toward a Proinflammatory State in Egyptian Patients: A Cross-Sectional Study. Journal of Interferon & Cytokine Research. 43(6). 257–268. 2 indexed citations
3.
Al-Tohamy, Rania, Sameh S. Ali, Fanghua Li, et al.. (2022). A critical review on the treatment of dye-containing wastewater: Ecotoxicological and health concerns of textile dyes and possible remediation approaches for environmental safety. Ecotoxicology and Environmental Safety. 231. 113160–113160. 2110 indexed citations breakdown →
4.
Gaber, Raouf, Sherief Abd‐Elsalam, Mai Khalaf, et al.. (2022). Ocular Manifestations in Patients with Coronavirus Disease 2019 (COVID-19): A Real World Multicenter Observational Study in Egypt. The Open Ophthalmology Journal. 16(1). 1 indexed citations
5.
Bedair, Alaa, Kamal Okasha, & Fotouh R. Mansour. (2022). Spectroscopic methods for COVID-19 detection and early diagnosis. Virology Journal. 19(1). 152–152. 13 indexed citations
6.
Okasha, Kamal, et al.. (2022). Association of Serum Osteoprotegerin Level With Myocardial Injury and Cardiovascular Calcification in Chronic Kidney Disease Patients. Frontiers in Medicine. 9. 814970–814970. 4 indexed citations
7.
Al-Tohamy, Rania, Sameh S. Ali, Meng Zhang, et al.. (2022). Can wood-feeding termites solve the environmental bottleneck caused by plastics? A critical state-of-the-art review. Journal of Environmental Management. 326(Pt A). 116606–116606. 25 indexed citations
8.
Gaber, Raouf, Sherief Abd‐Elsalam, Mai Khalaf, et al.. (2022). Ocular Manifestations in Patients with Coronavirus Disease 2019 (COVID-19): A Real World Multicenter Observational Study in Egypt. The Open Ophthalmology Journal. 16(1).
9.
El‐Ashmawy, Nahla E., Kamal Okasha, Tarek M. Mostafa, et al.. (2020). The plausible mechanisms of tramadol for treatment of COVID-19. Medical Hypotheses. 146. 110468–110468. 20 indexed citations
10.
Haggag, Yusuf A., Nahla E. El‐Ashmawy, & Kamal Okasha. (2020). Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection?. Medical Hypotheses. 144. 109957–109957. 93 indexed citations
13.
Hegab, Doaa Salah, et al.. (2014). Prospective study on prevalence of dermatological changes in patients under hemodialysis in hemodialysis units in Tanta University hospitals, Egypt. Clinical Cosmetic and Investigational Dermatology. 7. 313–313. 20 indexed citations
14.
Okasha, Kamal, et al.. (2012). Prevalence of HCV infections among hemodialysis patients in Al Gharbiyah Governorate, Egypt.. PubMed. 5(3). 145–7. 23 indexed citations
15.
Okasha, Kamal, et al.. (2011). Assessment of Fluid Status in Chronic Hemodialysis Patients: Role of the Doppler Echocardiography and Atrial Naturetic Peptide. Nephro-Urology Monthly. 3(2). 99–105. 2 indexed citations
16.
Sabry, Alaa, Hamdy Abo-Zenah, Ehab W. Wafa, et al.. (2010). Sleep disorders in hemodialysis patients.. PubMed. 21(2). 300–5. 44 indexed citations
17.
Okasha, Kamal, et al.. (1998). ANALYSIS OF THE RELATIONSHIP BETWEEN CHIMERISM AND THE ALLOGENEIC HUMORAL RESPONSE1. Transplantation. 66(8). 1028–1034. 3 indexed citations
18.
Baltzan, Marc, et al.. (1997). Fate of recurrent acute interstitial cellular rejection in an HLA identical kidney transplant recipient: impact of donor microchimerism.. PubMed. 48(5). 300–6. 8 indexed citations
19.
Shoker, Ahmed, Kamal Okasha, David P. Sheridan, Joanne Kappel, & Marc Baltzan. (1997). ALLOANTIGEN-BLOCKING ANTIBODIES IN SERA FROM HIGHLY SENSITIZED UREMIC PATIENTS. Transplantation. 64(6). 853–860. 1 indexed citations
20.
Shoker, Ahmed, et al.. (1997). Analysis of the in vitro effect of exogenous nitric oxide on human lymphocytes. Molecular and Cellular Biochemistry. 171(1-2). 75–83. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026